Suppliers / Merck S.A. de C.V

Merck S.A. de C.V

Mexico 2 duplicate records merged Updated 9 July 2026

Merck S.A. de C.V is a finished-dose manufacturer based in Mexico. It appears in 32 regulatory filings across 3 regulators, without an active US DMF or CEP on file. Its filings concentrate with MINSA (CR), INVIMA (CO) and COFEPRIS (MX). Its GMP standing is certified by ANVISA (Brazil), EMA and COFEPRIS (MX). Its most recent recorded inspection, by US FDA, closed on 30 January 2015 as VAI.

0
active US DMFs
0
valid CEPs
6
registered plants 1 with an FDA FEI number
32
filings across 3 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
2 of 2 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 30 January 2015 VAI US FDA
  • 23 August 2013 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Naucalpan, Colombia Not on file
NAUCALPAN DE JUAREZ, Mexico Not on file
Naucalpan, Mexico Not on file
Mexico, Mexico 3004641553
Cuautitlán Izcalli, Mexico Not on file
Naucalpan de Juárez, Mexico Not on file

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 29 None
INVIMA (CO) 2 None
COFEPRIS (MX) 1 2
ANVISA (Brazil) None 3
EMA None 2

Comparing suppliers?

Choose your molecules and target markets. Merck S.A. de C.V comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 30 January 2015.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates